SEYİTLER KİMYA SANAYİ A.Ş. Logo

SEYİTLER KİMYA SANAYİ A.Ş.

Manufacturer of medical plasters, wound dressings, and first-aid tapes.

SEYKM | IS

Overview

Corporate Details

ISIN(s):
TRESEYT00011 (+2 more)
LEI:
789000QODBWOP1OPEQ85
Country:
Türkiye
Address:
Turgutlu 1. OSB 2007 Cad. No:5-7 Turgutlu, 45400 MANİSA

Description

Seyitler Kimya Sanayi A.Ş., established in 1991, is a manufacturer of medical products. The company's portfolio includes a wide range of medical plasters, wound dressings, first-aid tapes, and solid medical wound products, including the plaster-cataplasm group. Operating from a large-scale production campus equipped with modern, high-capacity machinery, the company ensures manufacturing continuity and reliability. Seyitler Kimya emphasizes research and development, focusing on medical adhesive technologies through collaborations with universities and research institutions. This commitment drives the development of innovative and high-performance products for the healthcare sector. The company serves both domestic and international markets through a dedicated network of dealers and distributors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-25 06:38
Company General Info Form
English 4.2 KB
2025-11-20 12:04
Ege Teknopark Bölgesinde Şirket Kuruluşu Hk.
English 90.4 KB
2025-11-19 10:14
Finansal raporlama esaslarında değişiklik hk.
Turkish 17.6 KB
2025-11-19 07:09
Company General Info Form
English 2.8 KB
2025-11-19 07:04
Ege Teknopark Bölgesinde Şirket Kuruluşu Hk.
Turkish 17.3 KB
2025-10-30 16:11
30.09.2025 Sorumluluk Beyanı Hk.
Turkish 21.5 KB
2025-10-30 16:11
30.09.2025 Faaliyet Raporu Hk.
Turkish 1.1 MB
2025-10-30 16:11
30.09.2025 Faaliyet Raporu Hk.
English 10.9 KB
2025-10-30 16:11
Financial Report
Turkish 2.3 MB
2025-10-30 16:11
Financial Report
English 2.5 MB
2025-10-23 17:07
Marka İhlal Davası Hk
Turkish 51.4 KB
2025-10-17 17:04
Bağış Yapılması Hk.
Turkish 17.7 KB
2025-10-07 17:06
Tazminat Davası Hk.
English 46.7 KB
2025-10-07 17:05
Marka İhlal Davası Hk
Turkish 50.1 KB
2025-09-29 17:03
Bağımsız Denetim Kuruluşunun Belirlenmesi
Turkish 29.1 KB

Automate Your Workflow. Get a real-time feed of all SEYİTLER KİMYA SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SEYİTLER KİMYA SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SEYİTLER KİMYA SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Annexon, Inc. Logo
Clinical-stage biopharma developing complement medicines by inhibiting C1q.
United States of America
ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes cell therapies and orphan drugs using adult stem cells.
South Korea
065660
Antibiotice S.A. Logo
Pharmaceutical firm manufacturing generic medicines, anti-infectives, and APIs.
Romania
ATB
Apellis Pharmaceuticals, Inc. Logo
Biopharmaceutical company developing therapies by targeting the complement cascade.
United States of America
APLS
Apimeds Pharmaceuticals US, Inc. Logo
Clinical-stage biopharma developing a bee venom drug and AI digital treasury solutions.
United States of America
APUS
Apogee Therapeutics, Inc. Logo
Clinical-stage biotech developing biologics for immunological and inflammatory diseases.
United States of America
APGE
Apollomics Inc. Logo
Clinical-stage biotech developing innovative oncology and combination therapies.
United States of America
APLM
Apontis Pharma AG Logo
Develops and markets fixed-dose combination drugs (Single Pills) for chronic diseases.
Germany
APPH
Applied Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel drugs for rare metabolic and CNS diseases.
United States of America
APLT
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologics and biosimilar antibody-based therapeutics.
South Korea
003060

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.